Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UCAP: Undiagnosed Airflow Obstruction Management
NCT03148210Completed
- Sponsor
- Ottawa Hospital Research Institute
- Start
- Jun 2017
- Primary completion
- Jan 2024
- Countries
- 1
01
Overview
Randomised, open-label trial in asthma and chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by Ottawa Hospital Research Institute. Primary endpoint: Annual rate of patient initiated healthcare utilization events for respiratory illness at 12 months. Started Jun 2017; status: completed.
02
Conditions
asthmachronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT03148210.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03148210.